Illumina Inc ILMN
Analyst Ratings
- Consensus
- Moderate Buy — 9 Buy · 3 Hold · 2 Sell (14 analysts)
- Avg. Price Target
- $255.93 (+13.0% upside)
Key Stats
- Today's Range
- $223.33 – $236.01
- 50-Day Range
- $200.01 – $309.35
- 52-Week Range
- $88.00 – $309.35
- Volume
- 2.93 million shs
- Average Volume
- 2.64 million shs
- Market Cap
- $35.63 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 1.45%
- Days to Cover
- 3.51
About Illumina Inc
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Related Stocks
Compare head-to-head: ILMN vs WAT·ILMN vs RVTY·ILMN vs BIO·ILMN vs TXG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.